It has been fantastically exciting to launch CiteAb this week.

It was great to see lots of visitors searching, browsing for antibodies and adding publications, and reassuring that our infrastructure coped with ease.

One of the most satisfying things about launching was seeing users from across the globe visit CiteAb. This week we have welcomed visitors from fifty seven countries including expected nations such as the USA, UK, Japan and Australia, but also Tunisia, Turkey and Thailand.

Users have carried out thousands of searches and the most frequent searches included DCX, PirB, cd4 and P53.

We have had lots of positive feedback which is great to hear. We have also had many useful and challenging suggestions. Rest assured we will use these to help improve CiteAb and always welcome more comments.

To stay in touch with future developments follow on Twitter at @CiteAb, or find CiteAb on LinkedIn, Google+ and Facebook.

Finally a big thank you to the CiteAb team who have worked so hard and to all our visitors for trying CiteAb.